Status of rats myocardium under subchronic mercury exposure and its pharmacological correction

1. Aaseth J. et al.: Chelation in metal intoxication-Principles and paradigms. J Trace Elem Med Biol., 31, 260-266, 2015.10.1016/j.jtemb.2014.10.00125457281Search in Google Scholar

2. Avtandilov G.G. (1990): Medical morphometry. Guide. Medicine. (in Russian)Search in Google Scholar

3. Ballmann C. et al.: Histological and biochemical outcomes of cardiac pathology in mdx mice with dietary quercetin enrichment. Exp Physiol, 100, 12-22, 2015.10.1113/expphysiol.2014.08336025557727Search in Google Scholar

4. Bernhoft R.A.: Mercury toxicity and treatment: a review of the literature. J Environ Public Health,. 2012, 2012.10.1155/2012/460508325345622235210Search in Google Scholar

5. Busch J. et al.: The heavy metals cadmium, lead and mercury in raw materials of animal origin: evaluation of data from practice. Pharm Bio Sci Notes, 2015, 150-165, 2015.Search in Google Scholar

6. Cao Y. et al.: Chelation therapy in intoxications with mercury, lead and copper. J Trace Elem Med Biol., 31, 188-192, 2015.10.1016/j.jtemb.2014.04.01024894443Search in Google Scholar

7. Dziegiel P. et al.: Metallothioneins: Structure and Functions. Adv Anat Embryol Cell Biol, 218, 1-117, 2016.Search in Google Scholar

8. Figueredo F.G. et al.: Cytoprotective Effect of Lygodium venustum Sw. (Lygodiaceae) against Mercurium Chloride Toxicity. Scientifica (Cairo). 2016, 4154265, 2016.10.1155/2016/4154265478951527034899Search in Google Scholar

9. Foras L.D.: Quercetin in treatment cardiovascular. The radical Research., 39, 2005.Search in Google Scholar

10. Graham I. et al.: Fourth joint task force of European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil., 14, 2, S1-113, 2007.Search in Google Scholar

11. Jain A.K., Mehra N.K., Swarnakar N.K.: Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities. Curr Pharm Des., 21(30), 4441-4455, 2015.10.2174/138161282166615080315175826234792Search in Google Scholar

12. Kaminsky R. et al.: A study of impact of mercury chloride on myocardium in experiment. Georgian Med News., 251, 64-70, 2016.Search in Google Scholar

13. Kim K.H. et al.: A review on the distribution of Hg in the environment and its human health impacts. J Hazard Mater, 306, 376-385, 2016.10.1016/j.jhazmat.2015.11.03126826963Search in Google Scholar

14. Pierce E. (1962). Histochemistry theoretical and applied. M Moscow: Univ. foreign. Literature.Search in Google Scholar

15. Rafati-Rahimzadeh M. et al.: Current approaches of the management of mercury poisoning: need of the hour. Daru, 22, 46, 2014.10.1186/2008-2231-22-46405590624888360Search in Google Scholar

16. Sokurenko L.M. et al.: Mildronate protects neuroblasts against toxic influence of mercuric chloride in cell culture. Neurophysiology, 46(3), 271-273, 2014.10.1007/s11062-014-9440-7Search in Google Scholar